Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vocational rehabilitation strategies in schizophrenia with ziprasidone versus risperidone
2006-004891-10Phase 4Terminated
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Nov 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ziprasidone and risperidone in schizophrenia and Schizophrenia Spectrum and Other Psychotic Disorders (SZ) (2 arms), sponsored by Charité – Universitätsmedizin Berlin. Primary endpoint: Working Behaviour Inventory improvement. Started Nov 2006; status: terminated.
02
Drugs
ziprasidonerisperidone
03
Conditions
schizophreniaSchizophrenia Spectrum and Other Psychotic Disorders (SZ)
Beyond the preview
Go deeper on 2006-004891-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004891-10.